Question 1

How many shares of NKTR does MACKENZIE FINANCIAL CORP own?

Accepted Answer

MACKENZIE FINANCIAL CORP previously held 0 shares of NKTR (Nektar Therapeutics) before exiting the position in 2025-Q2.

Question 2

What is MACKENZIE FINANCIAL CORP's NKTR position worth?

Accepted Answer

MACKENZIE FINANCIAL CORP's NKTR position was last reported at $0 in 2025-Q2 before the exit.

Question 3

Is MACKENZIE FINANCIAL CORP buying or selling NKTR?

Accepted Answer

In 2025-Q2, MACKENZIE FINANCIAL CORP exited their NKTR position entirely (-100.0% change in shares).

Question 4

When did MACKENZIE FINANCIAL CORP first buy NKTR?

Accepted Answer

Based on available 13F filings, MACKENZIE FINANCIAL CORP first reported a position in NKTR in 2024-Q3. They have held the position across 16 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$25.76	0
2025-Q1	Increased	1.7M	+17.7%	$1.1M	0.0%	$11.10	29
2024-Q4	Increased	1.4M	+2604.1%	$1.3M	0.0%	$14.10	41
2024-Q3	Increased	52,118	+19.1%	$67,753	0.0%	$17.55	25